Journal article
Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study
Abstract
Objective: SARS-CoV-2 remains the third most common cause of death in North America. We studied the effects of methotrexate and tumor necrosis factor inhibitor (TNFi) on neutralization responses after COVID-19 vaccination in immune-mediated inflammatory disease (IMID). Methods: Prospective data and sera of adults with inflammatory bowel disease (IBD), rheumatoid arthritis (RA), spondyloarthritis (SpA), psoriatic arthritis (PsA), and systemic …
Authors
Hitchon CA; Bowdish DME; Boire G; Fortin PR; Flamand L; Chandran V; Dayam RM; Gingras A-C; Card CM; Colmegna I
Journal
Vaccines, Vol. 12, No. 9,
Publisher
MDPI
DOI
10.3390/vaccines12091061
ISSN
2076-393X